Coastline Trust Co Boosts Holdings in Agilent Technologies Inc (NYSE:A)

Coastline Trust Co grew its position in shares of Agilent Technologies Inc (NYSE:A) by 1.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,785 shares of the medical research company’s stock after buying an additional 330 shares during the quarter. Coastline Trust Co’s holdings in Agilent Technologies were worth $1,328,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of A. Artisan Partners Limited Partnership increased its holdings in Agilent Technologies by 0.6% in the 1st quarter. Artisan Partners Limited Partnership now owns 5,858,087 shares of the medical research company’s stock valued at $470,873,000 after acquiring an additional 36,359 shares during the last quarter. FMR LLC increased its holdings in Agilent Technologies by 2.9% in the 1st quarter. FMR LLC now owns 5,635,232 shares of the medical research company’s stock valued at $452,960,000 after acquiring an additional 159,653 shares during the last quarter. American Century Companies Inc. increased its holdings in Agilent Technologies by 20.6% in the 1st quarter. American Century Companies Inc. now owns 4,928,415 shares of the medical research company’s stock valued at $396,146,000 after acquiring an additional 840,850 shares during the last quarter. Geode Capital Management LLC increased its holdings in Agilent Technologies by 7.2% in the 4th quarter. Geode Capital Management LLC now owns 4,234,035 shares of the medical research company’s stock valued at $285,139,000 after acquiring an additional 285,330 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in Agilent Technologies by 1.5% in the 1st quarter. Northern Trust Corp now owns 3,864,956 shares of the medical research company’s stock valued at $310,666,000 after acquiring an additional 56,958 shares during the last quarter.

Shares of NYSE:A traded down $0.46 during trading hours on Thursday, hitting $71.74. The company’s stock had a trading volume of 1,302,557 shares, compared to its average volume of 2,328,189. Agilent Technologies Inc has a 52 week low of $61.01 and a 52 week high of $82.27. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.13 and a quick ratio of 1.72. The company has a market capitalization of $22.67 billion, a price-to-earnings ratio of 25.71, a P/E/G ratio of 1.98 and a beta of 1.41. The firm’s fifty day moving average price is $70.35 and its 200 day moving average price is $74.50.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 14th. The medical research company reported $0.76 EPS for the quarter, topping the consensus estimate of $0.72 by $0.04. The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.24 billion. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. Agilent Technologies’s revenue was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.67 EPS. On average, equities research analysts predict that Agilent Technologies Inc will post 3.08 earnings per share for the current fiscal year.

A number of equities analysts have commented on A shares. ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Friday, July 12th. Barclays cut shares of Agilent Technologies from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $86.00 to $78.00 in a research note on Monday, July 15th. Robert W. Baird reissued an “outperform” rating and issued a $82.00 price objective (up from $79.00) on shares of Agilent Technologies in a research note on Thursday, August 15th. Bank of America cut shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price objective for the company. in a research note on Tuesday, July 16th. Finally, Piper Jaffray Companies lifted their price objective on shares of Agilent Technologies from $83.00 to $86.00 and gave the stock an “overweight” rating in a research note on Thursday, August 15th. Six equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $84.77.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Read More: Google Finance Portfolio Workaround

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.